CytoDyn Inc. (CYDY): Total Liabilities
$123.69M
As of 2026-05-31
+0.8%
3-year compound annual growth
-4.2%
5-year compound annual growth
+42.5%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-05-31 | $123.69M | +8.4% | 2026-08-31, Balance as of period end |
| 2025-05-31 | $114.09M | -10.8% | 2026-08-31, Balance as of period end |
| 2024-05-31 | $127.89M | +5.9% | 2025-07-25, Balance as of period end |
| 2023-05-31 | $120.79M | -2.3% | 2024-08-15, Balance as of period end |
| 2022-05-31 | $123.58M | -19.3% | 2023-09-14, Balance as of period end |
| 2021-05-31 | $153.10M | +188.9% | 2022-08-15, Balance as of period end |
| 2020-05-31 | $52.99M | +77.9% | 2021-07-30, Balance as of period end |
| 2019-05-31 | $29.79M | +65.0% | 2020-08-14, Balance as of period end |
| 2018-05-31 | $18.06M | +97.2% | 2019-08-14, Balance as of period end |
| 2017-05-31 | $9.16M | +155.8% | 2018-07-27, Balance as of period end |
| 2016-05-31 | $3.58M | -76.7% | 2017-07-20, Balance as of period end |
| 2015-05-31 | $15.37M | +241.2% | 2016-07-19, Balance as of period end |
| 2014-05-31 | $4.51M | +2.8% | 2015-07-10, Balance as of period end |
| 2013-05-31 | $4.38M | -13.1% | 2014-07-10, Balance as of period end |
| 2012-05-31 | $5.04M | -28.0% | 2013-08-29, Balance as of period end |
| 2011-05-31 | $7.00M | n/a | 2012-08-22, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| CytoDyn Inc. (CYDY) | 2026-05-31 | $123.69M | +8.4% |
| Actuate Therapeutics, Inc. (ACTU) | 2025-12-31 | $6.11M | -33.7% |
| Exicure, Inc. (XCUR) | 2025-12-31 | $10.12M | +22.1% |
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | $1.48M | -56.9% |
| Biovie Inc. (BIVI) | 2026-06-30 | $3.98M | +56.1% |
| CalciMedica, Inc. (CALC) | 2025-12-31 | $20.23M | +275.8% |
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | $5.06M | -48.4% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $28.89M | +7.5% |
| Cingulate Inc. (CING) | 2025-12-31 | $12.56M | +69.6% |
Compare CYDY, ACTU, XCUR, CMMB side by side · Screen every company in Pharmaceutical Preparations ↗